Icagen, Inc. Reaffirms Recommendation to Shareholders to Tender Shares

RESEARCH TRIANGLE PARK, N.C., Aug. 29, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today that it has sent the following letter to stockholders affirming the Board's recommendation after receiving a letter from Pfizer Inc. (NYSE:PFE) on Friday, August 26, 2011 stating that Pfizer's best and final offer price is $6.00 per share:

Back to news